Editas Medicine, Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Editas Medicine, Inc. (0IFK.L) is 3.19

According to Editas Medicine, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.19. This represents a change of -0.53% compared to the average of 3.20 of the last 4 quarters.

Editas Medicine, Inc. (0IFK.L) Historical Current Ratio (quarterly & annually)

How has 0IFK.L Current Ratio performed in the past?

The mean historical Current Ratio of Editas Medicine, Inc. over the last ten years is 6.95. The current 3.19 Current Ratio has changed 4.48% with respect to the historical average. Over the past ten years (40 quarters), 0IFK.L's Current Ratio was at its highest in in the September 2016 quarter at 14.79. The Current Ratio was at its lowest in in the June 2025 quarter at 2.77.

Editas Medicine, Inc. (0IFK.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Editas Medicine, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Editas Medicine, Inc. (0IFK.L) Average Current Ratio

How has 0IFK.L Current Ratio performed in the past?

The current Current Ratio of Editas Medicine, Inc. (0IFK.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Editas Medicine, Inc. (0IFK.L) Current Ratio vs. Peers

How is 0IFK.L’s Current Ratio compared to its peers?

Editas Medicine, Inc.’s Current Ratio is less than Aclaris Therapeutics, Inc. (3.46), less than Abeona Therapeutics Inc. (6.63), less than Sangamo Therapeutics, Inc. (0), greater than Heron Therapeutics, Inc. (2.49), greater than Insight Molecular Diagnostics Inc. (2.00), less than Adicet Bio, Inc. (6.71), less than Corbus Pharmaceuticals Holdings, Inc. (5.71), greater than Atara Biotherapeutics Inc (1.98), greater than Integrated Diagnostics Holdings plc (0), greater than Codexis, Inc. (3.06),

Build a custom stock screener for Editas Medicine, Inc. (0IFK.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Editas Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Editas Medicine, Inc. (0IFK.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Editas Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.